---
title: Molecular Cartography Webinar | GENEWIZ from Azenta
---

[Skip to content](https://web.genewiz.com/omics-technology-spotlight/antibody-discovery-webinar#main-content)

[![GENEWIZ](https://web.genewiz.com/hubfs/GENEWIZ%20Brand%20Assets/GENEWIZ%20Logos/2025-04%20Current%20GENEWIZ%20Logos/GENEWIZ_Full-Color_Logo_PublicWeb_200x63.svg "GENEWIZ")](https://www.genewiz.com/)

 English

# An Innovative Antibody Discovery Workflow Leveraging Machine Learning to Prioritize Leads

 

**On-Demand Webinar**

 

![Omics-Tech-Spotlight\_Webinar4\_Laptop2](https://web.genewiz.com/hs-fs/hubfs/05-2023%20Genomics%20Innovation%20Spotlight/2024-02%20GEN%20-%20Technology%20Spotlight%20Webinar%20Series/Webinar%204%20-%20Antibody%20Discovery/Landing%20Page/Omics-Tech-Spotlight_Webinar4_Laptop2.png?width=400&height=242&name=Omics-Tech-Spotlight_Webinar4_Laptop2.png "Omics-Tech-Spotlight_Webinar4_Laptop2")

## About the workshop

Antibody generation and validation can be time-consuming, taking up to 6-12 months using traditional screening and production methods. Even after a thorough antibody campaign, candidates often result in late-stage failure. In this webinar, explore how advancements to antibody screening methods can help you discover and develop your mAb therapies more quickly and efficiently, allowing you to generate a diverse list of antibody candidates for recombinant production with promising biophysical profiles for commercialization.

### What you'll learn about

- The challenges of traditional antibody screening and production workflows
- Development of alternative technologies to increase speed, cost-effectiveness, antibody diversity, and more
- How high-throughput screening and computational approaches can generate 5-50x more antibody leads

 

Unable to attend live? Register today and we’ll send the recording to watch at your convenience.

## About the presenter

![TechSeries\_CrystalRichardson\_500px](https://web.genewiz.com/hubfs/05-2023%20Genomics%20Innovation%20Spotlight/2024-02%20GEN%20-%20Technology%20Spotlight%20Webinar%20Series/Webinar%204%20-%20Antibody%20Discovery/TechSeries_CrystalRichardson_500px.png)

#### Crystal Richardson, Ph.D.

Senior Business Partnership Manager​, Azenta Life Sciences

Dr. Crystal Richardson earned her Ph.D. from the University of Virginia with a degree in biomedical sciences. She has over six years of experience in molecular biology with a focus on clinical immunology. At Azenta, Dr. Richardson supports business operations and is our subject matter expert for adeno-associated virus (AAV) and recombinant antibody production.

### Watch now

![10014-D\_Omics-Tech-Spotlight\_EM-Graphic](https://web.genewiz.com/hubfs/05-2023%20Genomics%20Innovation%20Spotlight/2024-02%20GEN%20-%20Technology%20Spotlight%20Webinar%20Series/Webinar%201%20-%20Viral%20Vectors/Registration%20Page/10014-D_Omics-Tech-Spotlight_EM-Graphic.png)

Explore upcoming and on-demand omics webinars as part of our *Omics Technology Spotlight Webinar Series*

*[![EXPLORE WEBINARS](https://no-cache.hubspot.com/cta/default/3478602/interactive-156707206044.png)](https://web.genewiz.com/hs/cta/wi/redirect?encryptedPayload=AVxigLIBpdTCAu06f15onaH%2B24iPagiacz25mN7Yvq8K6aS0CsMjfYEQ51i3tWtY%2BWUSw06udxAi5Ic5x3plk2gROrF%2Ba6ydh5%2F0yj0Xxcq0NRumVJuYR20qVQJkRMswvCsgsYrVrpBxzme%2B4aMLjvgOzLY53ai8Lsh%2BQU8aISamwPTRw5KEx5mDDqYWQezE%2FB2Q8XQeKTf%2BlNOViA8H5u7dT2ifJDptQyCA2A%3D%3D&webInteractiveContentId=156707206044&portalId=3478602&hsLang=en)*